Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer.
about
Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinoma.Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell LinesCIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells
P2860
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer.
@ast
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer.
@en
type
label
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer.
@ast
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer.
@en
prefLabel
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer.
@ast
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer.
@en
P2093
P1476
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer
@en
P2093
Francesca Vignani
Marcello Tucci
Massimo Di Maio
P356
10.1016/J.CTRV.2017.01.002
P577
2017-01-11T00:00:00Z